Personalized medicine for locally advanced rectal cancer: five years of complete clinical response after neoadjuvant radiochemotherapy—a case report with a literature review

Personalized medicine for locally advanced rectal cancer: five years of complete clinical response after neoadjuvant radiochemotherapy—a case report with a literature review

We present a case report of a 73-year-old male patient with a complete clinical response following neoadjuvant radiochemotherapy of mid-rectal adenocarcinoma. The patient was initially diagnosed with stage IIIB microsatellite stable mid-rectal adenocarcinoma in February 2017. During restaging in Jun...

Full description

Bibliographic Details
Main Authors:	Dennis Obonyo, Verena Uslar, Dirk Weyhe, Navid Tabriz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Surgery
Subjects:	rectal cancer neoadjuvant radiochemotherapy (nRCT) complete clinical response (cCR) non-operative management (NOM) watch-and-wait (W&W) strategy personalized medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/fsurg.2024.1385378/full

Similar Items

The Predictors of Complete Pathologic Response in Rectal Cancer during the Total Neoadjuvant Therapy Era: A Systematic Review
by: Emily Flom, et al.
Published: (2023-12-01)

Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions?
by: Alexander Grabenbauer, et al.
Published: (2023-01-01)

Watch and wait strategies for rectal cancer: A systematic review
by: In Ja Park
Published: (2022-06-01)

High-Risk Clinicopathological and Genetic Features and Outcomes in Patients Receiving Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer
by: Sofía del Carmen, et al.
Published: (2021-06-01)

Survival outcomes of salvage surgery in the watch-and-wait approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
by: Wenjie Lin, et al.
Published: (2023-12-01)

Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
by: Hsu Yu-Jen, et al.
Published: (2022-09-01)

Predictive Factors of Histological Response after Preoperative Concomitant Radiochemotherapy in Middle and Low Rectal Cancer
by: Asmae Ouabdelmoumen, et al.
Published: (2018-09-01)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
by: Federica Papaccio, et al.
Published: (2020-12-01)

Watch and Wait Approach for Rectal Cancer
by: Carlos Cerdan-Santacruz, et al.
Published: (2023-04-01)

New Frontiers in Management of Early and Advanced Rectal Cancer
by: Jordan R. Wlodarczyk, et al.
Published: (2022-02-01)

Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and Wait
by: Quoc Riccardo Bao, et al.
Published: (2023-01-01)

Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?
by: Vincent Bourbonne, et al.
Published: (2023-01-01)

A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait
by: Angelita Habr-Gama, et al.
Published: (2023-06-01)

“Watch and wait” strategy (active dynamic follow-up) in the management of rectal cancer patients with a complete clinical response
by: Z. A. Dudaev, et al.
Published: (2022-04-01)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
by: Anita De Rossi, et al.
Published: (2011-04-01)

Late Local Recurrence after Neoadjuvant Therapy and Radical Resection for Locally Advanced Rectal Cancer
by: Adrian Salega, et al.
Published: (2024-01-01)

Watch and Wait Approach for Rectal Cancer Following Neoadjuvant Treatment: The Experience of a High Volume Cancer Center
by: Daniela Rega, et al.
Published: (2021-08-01)

Non-Operative Management of Patients with Rectal Cancer: Lessons Learnt from the OPRA Trial
by: Paolo Goffredo, et al.
Published: (2022-06-01)

Clinical Tools for Rectal Cancer Response Assessment following Neoadjuvant Treatment in the Era of Organ Preservation
by: Amalia J. Stefanou, et al.
Published: (2023-11-01)

Novel approaches to treatment of locally advanced rectal cancer
by: A. A. Kachmazov, et al.
Published: (2020-12-01)

Recent advances in rectal cancer treatment – are we on the right track?
by: Bengt Glimelius
Published: (2024-02-01)

Short-term and long-term treatment outcomes in patients with lower and middle rectal cancer with complete clinical and pathomorphological response after comprehensive treatment
by: Z. A. Dudaev, et al.
Published: (2022-04-01)

Clinical feasibility of the therapeutic strategies total neoadjuvant therapy and “watch and wait” in the treatment of rectal cancer patients with recurrence after clinical complete response
by: Dianyin Dai, et al.
Published: (2023-01-01)

Evaluating complete response prediction rates in locally advanced rectal cancer with different radiomics segmentation approaches
by: Gizem Kaval, et al.
Published: (2024-04-01)

Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer
by: Georg W. Wurschi, et al.
Published: (2024-03-01)

Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series
by: Oktar Asoglu, et al.
Published: (2022-11-01)

Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
by: Barbara Schuster, et al.
Published: (2021-12-01)

Delayed Surgery after Neoadjuvant Treatment for Rectal Cancer Does Not Lead to Impaired Quality of Life, Worry for Cancer, or Regret
by: Vincent Maurice Meyer, et al.
Published: (2021-02-01)

Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy
by: Rebecca Bütof, et al.
Published: (2022-07-01)

Post-Neoadjuvant Surveillance and Surgery as Needed Compared with Post-Neoadjuvant Surgery on Principle in Multimodal Treatment for Esophageal Cancer: A Scoping Review
by: Julian Hipp, et al.
Published: (2021-01-01)

Whether the watch-and-wait strategy has application value for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy? A network meta-analysis
by: Rui Du, et al.
Published: (2024-02-01)

The Conditioning of Adjuvant Chemotherapy for Stage II and III Rectal Cancer Determined by Postoperative Pathological Characteristics in Romania
by: Horia-Dan Liscu, et al.
Published: (2023-06-01)

Locally advanced rectal cancer with dMMR/MSI-H may be excused from surgery after neoadjuvant anti-PD-1 monotherapy: a multiple-center, cohort study
by: Renfang Yang, et al.
Published: (2023-06-01)

Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer
by: Victor Lopez-Lopez, et al.
Published: (2016-01-01)

Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
by: Hsin-Hua Lee, et al.
Published: (2022-05-01)

Does neoadjuvant rectal score predict treatment outcomes better than the all grading systems used in neoadjuvantly treated rectal cancer?
by: Fatma Sert, et al.
Published: (2023-10-01)

Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review
by: Andrea Brignoli, et al.
Published: (2023-10-01)

Complete response in patients with locally advanced rectal cancer after neoadjuvant treatment with nivolumab
by: Jianwei Zhang, et al.
Published: (2019-12-01)

Expression Levels of GHRH-Receptor, pAkt and Hsp90 Predict 10-Year Overall Survival in Patients with Locally Advanced Rectal Cancer
by: Dávid Fodor, et al.
Published: (2023-02-01)

Watch and Wait, Worth It?
by: Manoel Álvaro de Freitas Lins Neto, et al.
Published: (2022-12-01)